1. Home
  2. SRDX vs BRW Comparison

SRDX vs BRW Comparison

Compare SRDX & BRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • BRW
  • Stock Information
  • Founded
  • SRDX 1979
  • BRW 1987
  • Country
  • SRDX United States
  • BRW United States
  • Employees
  • SRDX N/A
  • BRW N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • BRW Trusts Except Educational Religious and Charitable
  • Sector
  • SRDX Health Care
  • BRW Finance
  • Exchange
  • SRDX Nasdaq
  • BRW Nasdaq
  • Market Cap
  • SRDX 416.3M
  • BRW 355.1M
  • IPO Year
  • SRDX 1998
  • BRW N/A
  • Fundamental
  • Price
  • SRDX $28.87
  • BRW $7.52
  • Analyst Decision
  • SRDX Buy
  • BRW
  • Analyst Count
  • SRDX 3
  • BRW 0
  • Target Price
  • SRDX $43.00
  • BRW N/A
  • AVG Volume (30 Days)
  • SRDX 138.2K
  • BRW 222.1K
  • Earning Date
  • SRDX 11-05-2025
  • BRW 01-01-0001
  • Dividend Yield
  • SRDX N/A
  • BRW 15.59%
  • EPS Growth
  • SRDX N/A
  • BRW N/A
  • EPS
  • SRDX N/A
  • BRW N/A
  • Revenue
  • SRDX $120,801,000.00
  • BRW N/A
  • Revenue This Year
  • SRDX N/A
  • BRW N/A
  • Revenue Next Year
  • SRDX $3.38
  • BRW N/A
  • P/E Ratio
  • SRDX N/A
  • BRW N/A
  • Revenue Growth
  • SRDX N/A
  • BRW N/A
  • 52 Week Low
  • SRDX $26.00
  • BRW $7.15
  • 52 Week High
  • SRDX $40.39
  • BRW $8.30
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 25.36
  • BRW 32.88
  • Support Level
  • SRDX $29.54
  • BRW $7.30
  • Resistance Level
  • SRDX $30.19
  • BRW $7.91
  • Average True Range (ATR)
  • SRDX 0.74
  • BRW 0.14
  • MACD
  • SRDX -0.21
  • BRW -0.04
  • Stochastic Oscillator
  • SRDX 6.26
  • BRW 26.97

About SRDX Surmodics Inc.

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.

About BRW Saba Capital Income & Opportunities Fund SBI

Saba Capital Income & Opportunities Fund is a diversified, closed-end management investment company. It seeks to provide investors with a high level of current income, with a secondary goal of capital appreciation. It invests globally in debt and equity securities of public and private companies, which includes, investing in closed-end funds, public and private debt instruments, and other securities.

Share on Social Networks: